Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
View Regular
Stephen V Liu, MD Profile picture
Stephen V Liu, MD
@StephenVLiu
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25; #HereWeGo #LetsGoBucs

Jun 22, 2020, 5 tweets

#AACR20 Outcomes in KEYNOTE-189 (1L carbo + pem + pembro in #NSCLC) by STK11 and KEAP1 status presented by Shirish Gadgeel. Analysis on a (sizable) subset of the ITT showed STK11mt/KEAP1wt 8.7%, STK11wt/KEAP1mt 13.5%, double STK11/KEAP1 mt 10%. #LCSM #OncoAlert

#AACR20 STK11 and KEAP1 mutations associated with lower PDL1 expression and higher #TMB. #LCSM #OncoAlert

#AACR20 Addition of pembro to chemo improved RR independent of STK11 and KEAP1 mutation status. #LCSM #OncoAlert

#AACR20 Addition of pembro to chemo improved PFS independent of STK11 and KEAP1 mutation status. Though outcomes seem notably better in the wild type population. Addition of pembro improved outcomes but degree of improvement larger in wild type - #LCSM #OncoAlert

#AACR20 Survival benefit seen with addition of pembro to chemo independent of STK11 and KEAP1 mutation status. Again, outcomes better in wild type and HR more impressive (OS HR 0.75 in STK11 mt vs 0.59 in STK11 wt) but benefit seen across the board. #LCSM #OncoAlert

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling